Sangamo Therapeutics
SGMO
SGMO
112 hedge funds and large institutions have $27.7M invested in Sangamo Therapeutics in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
-9
Holders Change %
-7.44%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
30
Reduced
32
Closed
24
Calls
$756K
Puts
$727K
Net Calls
+$29K
Net Calls Change
+$104K
Top Buyers
1 |
Renaissance Technologies
New York
|
+$1.99M |
2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$692K |
3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$658K |
4 |
UBS Group
Zurich,
Switzerland
|
+$345K |
5 |
Squarepoint
New York
|
+$332K |